BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30483806)

  • 21. Altered intracellular region of MUC1 and disrupted correlation of polarity-related molecules in breast cancer subtypes.
    Iizuka M; Nakanishi Y; Fuchinoue F; Maeda T; Murakami E; Obana Y; Enomoto K; Tani M; Sakurai K; Amano S; Masuda S
    Cancer Sci; 2015 Mar; 106(3):307-14. PubMed ID: 25556893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coexpression of PBX1 and EMP2 as Prognostic Biomarkers in Estrogen Receptor-Negative Breast Cancer via Data Mining.
    Qiu Y; Lu G; Wu Y
    J Comput Biol; 2020 Oct; 27(10):1509-1518. PubMed ID: 32216630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of hepatocyte growth factor/scatter factor receptor (c-Met) and MUC1 from the axillary fluid drainage in patients after breast cancer surgery.
    Greenberg R; Barnea Y; Schneebaum S; Kashtan H; Kaplan O; Skornik Y
    Isr Med Assoc J; 2003 Sep; 5(9):649-52. PubMed ID: 14509156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bioinformatics analysis of prognostic value of PITX1 gene in breast cancer.
    Wang Q; Zhao S; Gan L; Zhuang Z
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Messenger RNA determination of estrogen receptor, progesterone receptor, pS2, and plasminogen activator inhibitor-1 by competitive reverse transcription-polymerase chain reaction in human breast cancer.
    Tong D; Schneeberger C; Czerwenka K; Schmutzler RK; Speiser P; Kucera E; Concin N; Kubista E; Leodolter S; Zeillinger R
    Clin Cancer Res; 1999 Jun; 5(6):1497-502. PubMed ID: 10389938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of MUC1 expression by indole-3-carbinol.
    Lee IJ; Han F; Baek J; Hisatsune A; Kim KC
    Int J Cancer; 2004 May; 109(6):810-6. PubMed ID: 15027113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of MUC1 and MUC3 in the biology and prognosis of colorectal cancer.
    Duncan TJ; Watson NF; Al-Attar AH; Scholefield JH; Durrant LG
    World J Surg Oncol; 2007 Mar; 5():31. PubMed ID: 17349047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MUC1 gene overexpressed in breast cancer: structure and transcriptional activity of the MUC1 promoter and role of estrogen receptor alpha (ERalpha) in regulation of the MUC1 gene expression.
    Zaretsky JZ; Barnea I; Aylon Y; Gorivodsky M; Wreschner DH; Keydar I
    Mol Cancer; 2006 Nov; 5():57. PubMed ID: 17083744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overexpression of the MUC1 Gene in Iranian Women with Breast Cancer Micrometastasis.
    Mansouri N; Movafagh A; Soleimani S; Taheri M; Hashemi M; Heidary Pour A; Alizadeh Shargh S; Mosavi-Jarahi A; Sasaninejad Z; Zham H; Hajian P; Allah Moradi H; Mirzaei HR; Fardmanesh H; Ohadi M
    Asian Pac J Cancer Prev; 2016; 17(S3):275-8. PubMed ID: 27165238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DC-SCRIPT: nuclear receptor modulation and prognostic significance in primary breast cancer.
    Ansems M; Hontelez S; Looman MW; Karthaus N; Bult P; Bonenkamp JJ; Jansen JH; Sweep FC; Span PN; Adema GJ
    J Natl Cancer Inst; 2010 Jan; 102(1):54-68. PubMed ID: 20008677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of CGA as a novel estrogen receptor-responsive gene in breast cancer: an outstanding candidate marker to predict the response to endocrine therapy.
    Bieche I; Parfait B; Le Doussal V; Olivi M; Rio MC; Lidereau R; Vidaud M
    Cancer Res; 2001 Feb; 61(4):1652-8. PubMed ID: 11245479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BRCA1 Promoter Methylation and Expression - Associations with ER+, PR+ and HER2+ Subtypes of Breast Carcinoma.
    Kumar M; Sahu RK; Goyal A; Sharma S; Kaur N; Mehrotra R; Singh UR; Hedau S
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3293-3299. PubMed ID: 29286222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic silencing of CREB3L1 by DNA methylation is associated with high-grade metastatic breast cancers with poor prognosis and is prevalent in triple negative breast cancers.
    Ward AK; Mellor P; Smith SE; Kendall S; Just NA; Vizeacoumar FS; Sarker S; Phillips Z; Alvi R; Saxena A; Vizeacoumar FJ; Carlsen SA; Anderson DH
    Breast Cancer Res; 2016 Jan; 18(1):12. PubMed ID: 26810754
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies.
    Tewes M; Aktas B; Welt A; Mueller S; Hauch S; Kimmig R; Kasimir-Bauer S
    Breast Cancer Res Treat; 2009 Jun; 115(3):581-90. PubMed ID: 18679793
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer.
    Khodarev N; Ahmad R; Rajabi H; Pitroda S; Kufe T; McClary C; Joshi MD; MacDermed D; Weichselbaum R; Kufe D
    Oncogene; 2010 Feb; 29(6):920-9. PubMed ID: 19915608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MUC1 is upregulated in advanced prostate cancer and is an independent prognostic factor.
    Genitsch V; Zlobec I; Thalmann GN; Fleischmann A
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):242-7. PubMed ID: 27165976
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of a panel of novel genes for differentiating breast cancer from non-breast tissues.
    O'Brien N; O'Donovan N; Foley D; Hill AD; McDermott E; O'Higgins N; Duffy MJ
    Tumour Biol; 2007; 28(6):312-7. PubMed ID: 18253069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucin-1 correlates with survival, smoking status, and growth patterns in lung adenocarcinoma.
    Lappi-Blanco E; Mäkinen JM; Lehtonen S; Karvonen H; Sormunen R; Laitakari K; Johnson S; Mäkitaro R; Bloigu R; Kaarteenaho R
    Tumour Biol; 2016 Oct; 37(10):13811-13820. PubMed ID: 27481516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.
    Hasegawa H; Komoda M; Yamada Y; Yonezawa S; Tsutsumida H; Nagai K; Atogami S; Tsuruda K; Osaka A; Sasaki D; Yanagihara K; Imaizumi Y; Tsukasaki K; Miyazaki Y; Kamihira S
    Leuk Lymphoma; 2011 Jun; 52(6):1108-17. PubMed ID: 21599593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor-alpha mRNA in primary breast cancer: relationship to estrogen and progesterone receptor proteins and other prognostic factors.
    Chearskul S; Bhothisuwan K; Churintrapun M; Semprasert N; Onreabroi S
    Asian Pac J Allergy Immunol; 2002 Mar; 20(1):13-21. PubMed ID: 12125913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.